JAK inhibitors combined with bisphosphonates treatment for chronic diffuse sclerosing osteomyelitis of mandible: A 4-year follow-up

Saved in:
Bibliographic Details
Main Authors: Mu Wang, Weihua Han, Ge Kong, Shang-Zhu Zhang, Wen Zhang
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Journal of the Formosan Medical Association
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664625000981
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850246224682156032
author Mu Wang
Weihua Han
Ge Kong
Shang-Zhu Zhang
Wen Zhang
author_facet Mu Wang
Weihua Han
Ge Kong
Shang-Zhu Zhang
Wen Zhang
author_sort Mu Wang
collection DOAJ
format Article
id doaj-art-3978655954d04f11a64d256ca216ead3
institution OA Journals
issn 0929-6646
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series Journal of the Formosan Medical Association
spelling doaj-art-3978655954d04f11a64d256ca216ead32025-08-20T01:59:14ZengElsevierJournal of the Formosan Medical Association0929-66462025-06-01124657457710.1016/j.jfma.2025.02.032JAK inhibitors combined with bisphosphonates treatment for chronic diffuse sclerosing osteomyelitis of mandible: A 4-year follow-upMu Wang0Weihua Han1Ge Kong2Shang-Zhu Zhang3Wen Zhang4Department of Stomatology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, ChinaDepartment of Stomatology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, ChinaDepartment of Stomatology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases, The Ministry of Education Key Laboratory, Beijing, China; Corresponding author.Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases, The Ministry of Education Key Laboratory, Beijing, Chinahttp://www.sciencedirect.com/science/article/pii/S0929664625000981
spellingShingle Mu Wang
Weihua Han
Ge Kong
Shang-Zhu Zhang
Wen Zhang
JAK inhibitors combined with bisphosphonates treatment for chronic diffuse sclerosing osteomyelitis of mandible: A 4-year follow-up
Journal of the Formosan Medical Association
title JAK inhibitors combined with bisphosphonates treatment for chronic diffuse sclerosing osteomyelitis of mandible: A 4-year follow-up
title_full JAK inhibitors combined with bisphosphonates treatment for chronic diffuse sclerosing osteomyelitis of mandible: A 4-year follow-up
title_fullStr JAK inhibitors combined with bisphosphonates treatment for chronic diffuse sclerosing osteomyelitis of mandible: A 4-year follow-up
title_full_unstemmed JAK inhibitors combined with bisphosphonates treatment for chronic diffuse sclerosing osteomyelitis of mandible: A 4-year follow-up
title_short JAK inhibitors combined with bisphosphonates treatment for chronic diffuse sclerosing osteomyelitis of mandible: A 4-year follow-up
title_sort jak inhibitors combined with bisphosphonates treatment for chronic diffuse sclerosing osteomyelitis of mandible a 4 year follow up
url http://www.sciencedirect.com/science/article/pii/S0929664625000981
work_keys_str_mv AT muwang jakinhibitorscombinedwithbisphosphonatestreatmentforchronicdiffusesclerosingosteomyelitisofmandiblea4yearfollowup
AT weihuahan jakinhibitorscombinedwithbisphosphonatestreatmentforchronicdiffusesclerosingosteomyelitisofmandiblea4yearfollowup
AT gekong jakinhibitorscombinedwithbisphosphonatestreatmentforchronicdiffusesclerosingosteomyelitisofmandiblea4yearfollowup
AT shangzhuzhang jakinhibitorscombinedwithbisphosphonatestreatmentforchronicdiffusesclerosingosteomyelitisofmandiblea4yearfollowup
AT wenzhang jakinhibitorscombinedwithbisphosphonatestreatmentforchronicdiffusesclerosingosteomyelitisofmandiblea4yearfollowup